Literature DB >> 11713214

Induction of type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system.

W W Li1, C Le Goascogne, M Ramaugé, M Schumacher, M Pierre, F Courtin.   

Abstract

Thyroid hormones are essential for the development and repair of the peripheral nervous system. The type 2 deiodinase, which is responsible for the activation of T(4) into T(3), is induced in injured sciatic nerve. To obtain information on the type 3 deiodinase (D3) responsible for the degradation of thyroid hormones, we looked for its expression (mRNA and activity) in the sciatic nerve after injury. D3 was undetectable in the intact sciatic nerve of adult rats, but was rapidly and highly increased in the distal and proximal segments after nerve lesion. After cryolesion, D3 up-regulation disappeared after 3 d in the proximal segment, whereas it was sustained for 10 d in the distal segment, then declined to reach basal levels after 28 d, when functional recovery was completed. After a transsection preventing the nerve regeneration, up-regulation of D3 persisted up to 28 d at high levels in the distal segment. D3 was expressed in peripheral connective sheaths and in the internal endoneural compartment. D3 mRNA was inducible by 12-O-tetradecanoylphorbol-13-acetate in cultured fibroblasts or Schwann cells. In conclusion, induction of D3 in the peripheral nervous system after injury may play an important role during the regeneration process by adjusting intracellular T(3) levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713214     DOI: 10.1210/endo.142.12.8532

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

2.  Deiodination and cellular proliferation: parallels between development, differentiation, tumorigenesis, and now regeneration.

Authors:  Stephen A Huang
Journal:  Endocrinology       Date:  2009-01       Impact factor: 4.736

Review 3.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 4.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 5.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 6.  Physiological role and regulation of iodothyronine deiodinases: a 2011 update.

Authors:  A Marsili; A M Zavacki; J W Harney; P R Larsen
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 7.  Genomic imprinting of the type 3 thyroid hormone deiodinase gene: regulation and developmental implications.

Authors:  Marika Charalambous; Arturo Hernandez
Journal:  Biochim Biophys Acta       Date:  2012-04-04

8.  MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes.

Authors:  Gilles Mercier; Anna Maria Lennon; Benjamin Renouf; Audrey Dessouroux; Martine Ramaugé; Françoise Courtin; Michel Pierre
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 9.  Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage.

Authors:  Louis L Sarliève; Angeles Rodríguez-Peña; Keith Langley
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

10.  Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis.

Authors:  Luciana A Castroneves; Rebecca H Jugo; Michelle A Maynard; Jennifer S Lee; Ari J Wassner; David Dorfman; Roderick T Bronson; Chinweike Ukomadu; Agoston T Agoston; Lai Ding; Cristina Luongo; Cuicui Guo; Huaidong Song; Valeriy Demchev; Nicholas Y Lee; Henry A Feldman; Kristen R Vella; Roy W Peake; Christina Hartigan; Mark D Kellogg; Anal Desai; Domenico Salvatore; Monica Dentice; Stephen A Huang
Journal:  Endocrinology       Date:  2014-07-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.